X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs STRIDES PHARMA SCIENCE - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

STRIDES PHARMA SCIENCE 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS STRIDES PHARMA SCIENCE J.B.CHEMICALS/
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 17.0 19.7 86.0% View Chart
P/BV x 2.1 0.8 252.5% View Chart
Dividend Yield % 0.5 0.6 95.9%  

Financials

 J.B.CHEMICALS   STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
STRIDES PHARMA SCIENCE
Mar-18
J.B.CHEMICALS/
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs3631,147 31.7%   
Low Rs255642 39.7%   
Sales per share (Unadj.) Rs169.1317.2 53.3%  
Earnings per share (Unadj.) Rs16.67.8 211.6%  
Cash flow per share (Unadj.) Rs23.425.1 93.5%  
Dividends per share (Unadj.) Rs2.002.00 100.0%  
Dividend yield (eoy) %0.60.2 289.4%  
Book value per share (Unadj.) Rs172.5274.3 62.9%  
Shares outstanding (eoy) m83.5789.50 93.4%   
Bonus/Rights/Conversions BBESOP-  
Price / Sales ratio x1.82.8 64.8%   
Avg P/E ratio x18.6114.0 16.3%  
P/CF ratio (eoy) x13.235.7 37.0%  
Price / Book Value ratio x1.83.3 54.9%  
Dividend payout %12.025.5 47.3%   
Avg Mkt Cap Rs m25,82780,058 32.3%   
No. of employees `0003.82.5 150.5%   
Total wages/salary Rs m2,5114,341 57.9%   
Avg. sales/employee Rs Th3,747.411,325.8 33.1%   
Avg. wages/employee Rs Th665.71,731.4 38.4%   
Avg. net profit/employee Rs Th367.8280.1 131.3%   
INCOME DATA
Net Sales Rs m14,13528,394 49.8%  
Other income Rs m366941 38.9%   
Total revenues Rs m14,50129,334 49.4%   
Gross profit Rs m2,1783,965 54.9%  
Depreciation Rs m5701,540 37.0%   
Interest Rs m351,962 1.8%   
Profit before tax Rs m1,9401,403 138.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-168 0.0%   
Extraordinary Inc (Exp) Rs m0-436 0.0%   
Tax Rs m55297 567.6%   
Profit after tax Rs m1,387702 197.6%  
Gross profit margin %15.414.0 110.3%  
Effective tax rate %28.56.9 410.7%   
Net profit margin %9.82.5 396.9%  
BALANCE SHEET DATA
Current assets Rs m10,47024,836 42.2%   
Current liabilities Rs m2,74918,993 14.5%   
Net working cap to sales %54.620.6 265.4%  
Current ratio x3.81.3 291.3%  
Inventory Days Days5571 77.8%  
Debtors Days Days78113 68.5%  
Net fixed assets Rs m5,81134,289 16.9%   
Share capital Rs m167895 18.7%   
"Free" reserves Rs m14,24823,651 60.2%   
Net worth Rs m14,41624,546 58.7%   
Long term debt Rs m015,513 0.0%   
Total assets Rs m17,64965,437 27.0%  
Interest coverage x56.61.7 3,298.6%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.4 184.6%   
Return on assets %8.14.1 197.9%  
Return on equity %9.62.9 336.4%  
Return on capital %13.76.9 198.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16415,697 39.3%   
Fx outflow Rs m1,334735 181.5%   
Net fx Rs m4,82914,962 32.3%   
CASH FLOW
From Operations Rs m1,2311,871 65.8%  
From Investments Rs m-2085,826 -3.6%  
From Financial Activity Rs m-595-10,157 5.9%  
Net Cashflow Rs m427-2,615 -16.3%  

Share Holding

Indian Promoters % 55.4 27.7 200.0%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 37.8 9.0%  
FIIs % 3.9 8.6 45.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 25.9 142.9%  
Shareholders   30,437 56,241 54.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  DR. REDDYS LAB  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slips below 38,000-Mark; Yes Bank Jumps 9%(12:30 pm)

Share markets in India are presently trading deep in the red as investors were disappointed after the government refused any respite to foreign investors.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (4QFY19); Net Profit Up 7919.8% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, STRIDES PHARMA SCIENCE has posted a net profit of Rs 650 m (up 7919.8% YoY). Sales on the other hand came in at Rs 8 bn (up 26.4% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY19); Net Profit Down 27.5% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, STRIDES PHARMA SCIENCE has posted a net profit of Rs 316 m (down 27.5% YoY). Sales on the other hand came in at Rs 8 bn (up 6.1% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

STRIDES PHARMA SCIENCE 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of STRIDES PHARMA SCIENCE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of STRIDES PHARMA SCIENCE. Also includes updates on the valuation of STRIDES PHARMA SCIENCE.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

The Electric Vehicle Disruption is Great News for this Smallcap Stock(Profit Hunter)

Jul 15, 2019

While big auto makers are finding the transition difficult and crying foul, this small cap company is already leading and benefitting from the electric vehicle disruption in the auto sector.

7 Stocks to Profit From an Irreversible Trend(The 5 Minute Wrapup)

Jul 18, 2019

Credit growth is likely to accelerate in India in the next decade. Here's how you can benefit from this megatrend.

Budget an Icing on the Cake for This Smart Money Backed Affordable Housing Stock(The 5 Minute Wrapup)

Jul 10, 2019

Affordable housing is one of the most straightforward growth stories in India. This will help the real estate sector to come out of the slump.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jul 22, 2019 01:05 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS